Clinical Trials Browser

Breakthrough Pain × Head & Neck × Clear all

NCT02869321 2019-05-13

ANTALGIP

Phase 4 Completed

Head and Neck Neoplasms, Breakthrough Pain

NCT02050503 2015-03-17

CP073

Head & NeckOther

Head and Neck Neoplasms, Mucositis, Breakthrough Pain